Apotex Revenue and Competitors
Estimated Revenue & Valuation
- Apotex's estimated annual revenue is currently $1.4B per year. 0
Employee Data
- 00
Apotex's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO Apotex Inc. | Reveal Email/Phone |
2 | President & CEO | Reveal Email/Phone |
3 | President & CEO | Reveal Email/Phone |
4 | CIO Consultant | Reveal Email/Phone |
5 | Chief Corporate Development Officer | Reveal Email/Phone |
6 | Chief Legal Officer | Reveal Email/Phone |
7 | Chief Operations Officer | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Chief Staff | Reveal Email/Phone |
10 | Former VP International Sales and Marketing | Reveal Email/Phone |
Apotex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $32.2M | 160 | N/A | N/A | N/A |
#2 | $15.1M | 75 | 23% | N/A | N/A |
#3 | $341.9M | 1701 | N/A | N/A | N/A |
#4 | $16.7M | 83 | 43% | N/A | N/A |
#5 | $10.9M | 54 | -4% | N/A | N/A |
#6 | $11.3M | 56 | -2% | N/A | N/A |
#7 | $211.7M | 1297 | 4% | N/A | N/A |
#8 | $29.1M | 145 | 5% | N/A | N/A |
#9 | $9.4M | 47 | -2% | N/A | N/A |
#10 | $11.9M | 59 | -8% | N/A | N/A |
What Is Apotex?
When it comes to affordable healthcare solutions, you can count on Apotex. One more way we are Advancing Generics.
keywords:N/AN/A
Total Funding
N/A
Number of Employees
$1.4B
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Apotex News
2022-04-20 - Calcitonin Salmon Market Size, Scope And Forecast | Novartis ...
Novartis, Sanofi, Mylan Pharmaceuticals, Apotex, Upsher-Smith Laboratories, Ferring Pharmaceuticals, Par Pharmaceutical, Torrent,...
2022-04-20 - Clarithromycin Tablets Market Size, Scope And Forecast ...
Abbvie, Abbott, Mylan, Apotex, Sandoz, Takeda Pharmaceuticals, Teva Pharmaceutical, Sun Pharmaceutical, Aurobindo Pharma, Mayne Pharma,...
2022-04-06 - Apotex Corp. Launches Generic of Abraxane® in the United ...
Paclitaxel protein-bound particles for injectable suspension is indicated for the treatment of metastatic breast cancer, non-small cell lung...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 1 | -50% | N/A |
#2 | $0.1M | 2 | -33% | N/A |
#3 | $0.1M | 2 | 0% | N/A |
#4 | $0.2M | 3 | N/A | N/A |
#5 | $0.2M | 3 | -25% | N/A |